These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6455513)

  • 1. Enzymatic assays for 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline, a promising new "nonclassical" antifolate.
    Heusner JJ; McCormack JJ
    J Pharm Sci; 1981 Jul; 70(7):827-8. PubMed ID: 6455513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of metabolism of the 'nonclassical' antifolate, trimetrexate (2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline) by drugs containing an imidazole moiety.
    Heusner JJ; Franklin MR
    Pharmacology; 1985; 30(5):266-72. PubMed ID: 3159026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro.
    Kamen BA; Eibl B; Cashmore A; Bertino J
    Biochem Pharmacol; 1984 May; 33(10):1697-9. PubMed ID: 6233981
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacology and toxicity of a potent "nonclassical" 2,4-diamino quinazoline folate antagonist, trimetrexate, in normal dogs.
    Weir EC; Cashmore AR; Dreyer RN; Graham ML; Hsiao N; Moroson BA; Sawicki WL; Bertino JR
    Cancer Res; 1982 May; 42(5):1696-702. PubMed ID: 6461409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 2,4-Diamino-5-chloroquinazoline analogues of trimetrexate and piritrexim: synthesis and antifolate activity.
    Rosowsky A; Mota CE; Wright JE; Queener SF
    J Med Chem; 1994 Dec; 37(26):4522-8. PubMed ID: 7799402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformational analysis of antineoplastic antifolates: the crystal structure of trimetrexate and the aminopterine derivative 4-[N-[(2,4-diamino-6-pteridinyl)methyl]amino]benzoic acid.
    Sutton PA; Cody V
    J Med Chem; 1987 Oct; 30(10):1843-8. PubMed ID: 2958629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 5-methyl-5-deaza nonclassical antifolates as inhibitors of dihydrofolate reductases and as potential antipneumocystis, antitoxoplasma, and antitumor agents.
    Gangjee A; Shi J; Queener SF; Barrows LR; Kisliuk RL
    J Med Chem; 1993 Oct; 36(22):3437-43. PubMed ID: 8230134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potent in vitro and in vivo antitoxoplasma activity of the lipid-soluble antifolate trimetrexate.
    Allegra CJ; Kovacs JA; Drake JC; Swan JC; Chabner BA; Masur H
    J Clin Invest; 1987 Feb; 79(2):478-82. PubMed ID: 2948969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline (tmq), a potent non-classical folate antagonist inhibitor--I effect on dihydrofolate reductase and growth of rodent tumors in vitro and in vivo.
    Bertino JR; Sawicki WL; Moroson BA; Cashmore AR; Elslager EF
    Biochem Pharmacol; 1979 Jun; 28(12):1983-7. PubMed ID: 454469
    [No Abstract]   [Full Text] [Related]  

  • 10. The antifolate trimetrexate: observation of the enzyme-binding conformation.
    Hempel A; Camerman N; Mastropaolo D; Camerman A
    Acta Crystallogr C; 2000 Oct; 56 ( Pt 10)():1225-7. PubMed ID: 11025305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2,4-Diamino-5-substituted-quinazolines as inhibitors of a human dihydrofolate reductase with a site-directed mutation at position 22 and of the dihydrofolate reductases from Pneumocystis carinii and Toxoplasma gondii.
    Rosowsky A; Mota CE; Queener SF; Waltham M; Ercikan-Abali E; Bertino JR
    J Med Chem; 1995 Mar; 38(5):745-52. PubMed ID: 7877140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
    Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
    Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nonclassical 2,4-diamino-8-deazafolate analogues as inhibitors of dihydrofolate reductases from rat liver, Pneumocystis carinii, and Toxoplasma gondii.
    Gangjee A; Zhu Y; Queener SF; Francom P; Broom AD
    J Med Chem; 1996 Apr; 39(9):1836-45. PubMed ID: 8627607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of plasma trimetrexate levels using gas chromatography-mass spectrometry with selected-ion monitoring.
    Stetson PL; Ensminger WD
    J Chromatogr; 1986 Nov; 383(1):69-76. PubMed ID: 2950125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stability of trimetrexate, a new non-classical antifolate, in infusion solutions.
    Stetson PL; Shukla UA; Ensminger WD
    J Chromatogr; 1989 Feb; 464(1):163-71. PubMed ID: 2523896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trimetrexate: clinical development of a nonclassical antifolate.
    O'Dwyer PJ; DeLap RJ; King SA; Grillo-Lopez AJ; Hoth DF; Leyland-Jones B
    NCI Monogr; 1987; (5):105-9. PubMed ID: 2963228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activity of antifolates against Pneumocystis carinii dihydrofolate reductase and identification of a potent new agent.
    Allegra CJ; Kovacs JA; Drake JC; Swan JC; Chabner BA; Masur H
    J Exp Med; 1987 Mar; 165(3):926-31. PubMed ID: 2950200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic disposition of trimetrexate, a nonclassical dihydrofolate reductase inhibitor, in rat and dog.
    Wong BK; Woolf TF; Chang T; Whitfield LR
    Drug Metab Dispos; 1990; 18(6):980-6. PubMed ID: 1981548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric phase I trial and pharmacokinetic study of trimetrexate.
    Balis FM; Patel R; Luks E; Doherty KM; Holcenberg JS; Tan C; Reaman GH; Belasco J; Ettinger LJ; Zimm S
    Cancer Res; 1987 Sep; 47(18):4973-6. PubMed ID: 2957048
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.